Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
32
33
Next >
Week In Review: Qitan Raises $101 Million For Nanopore Sequencing Devices
January 14, 2023
Tickers
ASND
AZN
LLY
TAK
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
The Viral “Tripledemic” Opportunity
January 14, 2023
Tickers
AZN
CVS
HLN
JNJ
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
A "Multi-Bagger" Portfolio For 2023 - Introduction
January 14, 2023
Tickers
AAWH
ACB
ACRDF
AYRWF
Tags
Healthcare
Consumer Goods
Stocks / Equities
From
TalkMarkets
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
January 12, 2023
Tickers
BNTX
EVOL
IWM
JNJ
Tags
Healthcare
Pharma/Biotech
Market News
From
TalkMarkets
Thoughts For Thursday: All Eyes On The CPI
January 12, 2023
Tickers
BIO
ETSY
GEHC
SPX
Tags
Technology
Consumer Goods
ETFs
From
TalkMarkets
Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish
January 11, 2023
Tickers
BIIB
BMY
IEF
LLY
Tags
Bonds
Pharma/Biotech
Market News
From
TalkMarkets
Cannabis Category Performances Ranged From +5% To -3% Last Week
January 10, 2023
Tickers
AYRWF
CURLF
GTBIF
MO
Tags
Healthcare
Consumer Goods
Market News
From
TalkMarkets
My "Rags-To-Riches" Portfolio For 2023: An Introduction
January 08, 2023
Tickers
ATAI
BYND
CGC
CMPS
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Top Picks For 2023: Catalyst Pharmaceuticals - Sunday, Jan. 8
January 08, 2023
Tickers
CPRX
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
ETFs To Buy For 2023 After S&P 500's Worst Year Since 2008
January 08, 2023
Tickers
DIV
SPY
SPYD
XBI
Tags
Energy
ETFs
Pharma/Biotech
From
TalkMarkets
Week In Review: WuXi Biologics Out-Licenses Four TCE Antibodies To GSK In $1.5 Billion Pact
January 07, 2023
Tickers
GSK
WXXWY
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Top Picks For 2023: Anavex Life Sciences
January 06, 2023
Tickers
AVXL
BIIB
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Intraday Technical Analysis Of Walgreens Boots Alliance Inc.
January 05, 2023
Tickers
WBA
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Top Picks For 2023: Esperion
January 02, 2023
Tickers
ESPR
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Top Picks For 2023: Catalyst Pharmaceuticals
January 02, 2023
Tickers
BMRN
CPRX
ESALY
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
7 Monster Stock Market Predictions – The Week Of January 3, 2023 Edition
January 02, 2023
Tickers
LLY
META
MRK
SPY
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
The 5 Cannabis Category Indices Ranged From +0.39% To -72.2% In 2022
January 02, 2023
Tickers
AYRWF
CURLF
GTBIF
TCNNF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
6 Largest Psychedelic Drug Stocks Were -20% In December
January 02, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Dow Stock Dogs Performed In 2022
January 01, 2023
Tickers
CSCO
JPM
KO
MRK
Tags
Consumer Goods
Technology
Financial
From
TalkMarkets
Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion
December 31, 2022
Tickers
HKMPF
INCY
MRK
WXXWY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
3 Healthcare Stocks To Buy For 2023
December 29, 2022
Tickers
HUM
PFE
PHG
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
20 Favorite Biotech & Medical Stocks For 2023
December 28, 2022
Tickers
ACLX
AKRO
ETNB
KDNY
Tags
Healthcare
Pharma/Biotech
Market News
From
TalkMarkets
12 Recession-Proof Stocks
December 26, 2022
Tickers
ABT
ATO
CL
CNI
Tags
Energy
Financial
Pharma/Biotech
From
TalkMarkets
Largest Psychedelic Stocks DOWN 8% Last Week; DOWN 22% So Far This Month
December 25, 2022
Tickers
AWKNF
DELCF
FTHWF
IBOGF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Cannabis Category Performances Ranged From +0.5% To -17% Last Week
December 25, 2022
Tickers
ATAI
BTI
BUD
CMPS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Top Biotech Companies Are Making Steady Progress In Developing Treatments To Fight Alzheimer’s Disease
December 21, 2022
Tickers
BIIB
LLY
PRTA
RHHBY
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Tuesday Talk: Where is Santa?
December 20, 2022
Tickers
ABBV
GILD
IWM
LLY
Tags
Stocks / Equities
Market News
Communications
From
TalkMarkets
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro
December 19, 2022
Tickers
ABBV
GILD
IBB
LLY
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
Bayer: Aspirin To Crop Protection
December 18, 2022
Tickers
BAYRY
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Major Psychedelic Drug Stocks Down Another 7% This Week; Now Down 54% YTD
December 18, 2022
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.